Evaluación del impacto de la pandemia COVID-19 en el diagnóstico y tratamiento de pacientes con cáncer de mama tratadas en Clínica Alemana de Santiago

Barriga S, Carolina; Camacho N, Jamile; Román L, Eugenio; Retamal R, Tatiana; Cádiz V, Fernando; Gallego A, Marcela; Carvajal H, Daniel.
Rev. cir. (Impr.) ; 73(3): 301-306, jun. 2021. tab
Artículo en Español | LILACS | ID: biblio-1388816

Documentos relacionados

  1. Highly specialized Breast Centers did not experience delay of care during COVID-19 pandemic in Italy: the Senonetwork experience.
  2. Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system.
  3. Tissue-resident FOLR2<sup>+</sup> macrophages associate with CD8<sup>+</sup> T cell infiltration in human breast cancer.
  4. The Impact of Health Inequities on Population-Based Breast Cancer Survival in a Colombian Population, 2008-2015.
  5. European quality indicators developed by the European Commission Initiative on Breast Cancer: a first nationwide assessment for the Dutch setting.
  6. Delayed breast cancer presentation, diagnosis, and treatment in Kenya.
  7. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021.
  8. Treatment Patterns and Survival Outcomes in Patients With Breast Cancer on Medicaid, Pre- and Post-Expansion.
  9. Impact of COVID-19 Restrictions on Stage of Breast Cancer at Presentation and Time to Treatment at an Urban Safety-Net Hospital.
  10. Association between weight change and breast cancer prognosis.